Q2 2023 Chromadex Corp Earnings Call Transcript
Hello. My name is Ayesha, and I will be your conference operator today. At this time, I would like to welcome everyone to the ChromaDex Second Quarter 2023 Conference Call. (Operator Instructions)
Thank you, Kendall Knysch. You may begin your conference.
Thank you. Good afternoon, and welcome to ChromaDex Corporation's second quarter 2023 results investor call. With us today are ChromaDex's Chief Executive Officer, Rob Fried; Chief Financial Officer, Brianna Gerber; and Senior Vice President of Scientific and Regulatory Affairs, Dr. Andrew Shao, who will join in the call for Q&A.
Today's conference call may include forward-looking statements, including statements relating to ChromaDex's research and development and clinical trial plans and the timing and results of such trials, the timing of future regulatory filings, the expansion of the sale of Tru Niagen in new markets, business development opportunities, future financial results, cash needs, operating performance, investor interest and business prospects and opportunities as
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |